These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17408248)

  • 1. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
    Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
    J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
    Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships in platinum-acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity.
    Ackley MC; Barry CG; Mounce AM; Farmer MC; Springer BE; Day CS; Wright MW; Berners-Price SJ; Hess SM; Bierbach U
    J Biol Inorg Chem; 2004 Jun; 9(4):453-61. PubMed ID: 15067524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.
    Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U
    J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
    Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
    Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
    Hess SM; Mounce AM; Sequeira RC; Augustus TM; Ackley MC; Bierbach U
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):337-43. PubMed ID: 15895232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
    Budiman ME; Alexander RW; Bierbach U
    Biochemistry; 2004 Jul; 43(26):8560-7. PubMed ID: 15222767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
    Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)propane]dichloroplatinum(II) complexes.
    Dufrasne F; Gelbcke M; Schnurr B; Gust R
    Arch Pharm (Weinheim); 2002 May; 335(5):229-39. PubMed ID: 12210780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
    Baruah H; Wright MW; Bierbach U
    Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH and thermo dual stimulus-responsive liposome nanoparticles for targeted delivery of platinum-acridine hybrid agent.
    Zhou Q; You C; Ling Y; Wu H; Sun B
    Life Sci; 2019 Jan; 217():41-48. PubMed ID: 30476500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
    Barry CG; Baruah H; Bierbach U
    J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
    Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
    Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
    J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
    Zák F; Turánek J; Kroutil A; Sova P; Mistr A; Poulová A; Mikolin P; Zák Z; Kasná A; Záluská D; Neca J; Sindlerová L; Kozubík A
    J Med Chem; 2004 Jan; 47(3):761-3. PubMed ID: 14736257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
    Bekhit AA; El-Sayed OA; Al-Allaf TA; Aboul-Enein HY; Kunhi M; Pulicat SM; Al-Hussain K; Al-Khodairy F; Arif J
    Eur J Med Chem; 2004 Jun; 39(6):499-505. PubMed ID: 15183908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, cytotoxicity and DNA-binding levels of ammine/propylamine platinum(II) complexes with carboxylates.
    Zhang J; Zhao X
    Eur J Med Chem; 2007 Feb; 42(2):286-91. PubMed ID: 17084487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.
    Suryadi J; Bierbach U
    Chemistry; 2012 Oct; 18(41):12926-34. PubMed ID: 22987397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based antitumor drugs containing enantiomerically pure alpha-trifluoromethyl alanine as ligand.
    Margiotta N; Papadia P; Lazzaro F; Crucianelli M; De Angelis F; Pisano C; Vesci L; Natile G
    J Med Chem; 2005 Dec; 48(24):7821-8. PubMed ID: 16302821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.